↓ Skip to main content

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review

Overview of attention for article published in Infectious Diseases of Poverty, May 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
53 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
Published in
Infectious Diseases of Poverty, May 2022
DOI 10.1186/s40249-022-00977-x
Pubmed ID
Authors

Jingjing Lv, Hui Wu, Junjie Xu, Jiaye Liu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 15%
Student > Master 5 9%
Professor 3 6%
Student > Ph. D. Student 3 6%
Student > Doctoral Student 2 4%
Other 6 11%
Unknown 26 49%
Readers by discipline Count As %
Nursing and Health Professions 8 15%
Medicine and Dentistry 6 11%
Veterinary Science and Veterinary Medicine 2 4%
Engineering 2 4%
Agricultural and Biological Sciences 2 4%
Other 7 13%
Unknown 26 49%